FACIT

FACIT is an organization established by the Ontario Institute for Cancer Research (OICR) to support the commercialization, technology transfer, and development activities of oncology innovations in Ontario. It aims to attract research and development investment in Ontario and facilitate the market entry of promising cancer-related technologies. FACIT is based in Toronto, Ontario.

FACIT invests in oncology innovations, including therapeutics, imaging, diagnostics, and technology platforms. It manages a diverse portfolio of Ontario oncology assets that span all stages of commercialization, from proof-of-concept to clinical development. The organization employs a venture capital approach to identify and support technologies with high potential to address unmet oncology needs.

FACIT offers funding initiatives including the Prospects Fund for early-stage proof-of-concept studies and the Compass Rose Fund for early-stage development of cancer research innovations. It provides mentorship, access to a network of oncology experts, and commercialization support.

Q: What types of innovations does FACIT support? A: FACIT supports Ontario-based innovations related to oncology and cancer care. Q: How can I apply for funding? A: Applications can be submitted through the contact form on our website. Q: What is the funding range? A: The Compass Rose Fund typically invests between $1M to $5M.